Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: Comparison of T-cell lymphoma with and without hemophagocytic syndrome

References

• Risdall R J, McKenna R W, Nesbit M E, Krivit W, Balfour H H, Jr, Simmons R L, et al. Virus associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979; 44: 993–1002
   PubMed Web of Science ®Google Scholar
• Cheng A L, Su I J, Chen Y C, Uen W C, Wang C H. Characteristic clinicopathologic features of Epstein-Barr virus associated peripheral T-cell lymphoma. Cancer 1993; 72: 909–916
   PubMed Web of Science ®Google Scholar
• Cheung M M, Chan J K, Lau W H, Foo W, Chan P T, Ng C S, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 1998; 16: 70–77
   PubMed Web of Science ®Google Scholar
• Linn Y C, Tien S L, Lim L C, Lee L H, Teoh G, Goh Y T, et al. Haemophagocytosis in bone marrow aspirate: a review of the clinical course of 10 cases. Acta Haematol 1995; 94: 182–191
   PubMed Web of Science ®Google Scholar
• Takahashi N, Miura I, Chubachi A, Miura A B, Nakamura S. A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma. Int J Hematol 2001; 74: 303–308
   PubMed Web of Science ®Google Scholar
• Gutierrez A, Solano C, Ferrandez A, Marugan I, Terol M J, Benet I, et al. Peripheral T-cell lymphoma associated consecutively with hemophagocytic lymphohistiocytosis and hypereosinophilic syndrome. Eur J Haematol 2003; 71: 303–306
   PubMed Web of Science ®Google Scholar
• Rudiger T, Weisenburger D D, Anderson J R, Armitage J O, Diebold J, MacLennan K A, et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 2002; 13: 140–149
   PubMed Web of Science ®Google Scholar
• The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909–3918
   PubMed Web of Science ®Google Scholar
• Ascani S, Zinzani P L, Gherlinzoni F, Sabattini E, Briskomatis A, de Vivo A, et al. Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. classification. Ann Oncol 1997; 8: 583–592
   PubMed Web of Science ®Google Scholar
• A predictive model for aggressive non-Hodgkin's lymphoma: the International NHL Prognostic Factors Project. N Engl J Med 1993; 329: 987–994
   PubMed Web of Science ®Google Scholar
• Janka G E, Schneider E M. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 2004; 124: 4–14
   PubMed Web of Science ®Google Scholar
• Takahashi N, Chubachi A, Miura I, Nakamura S, Miura A B. Lymphoma associated hemophagocytic syndrome in Japan. Rinsho Ketsueki 1999; 40: 542–549
   PubMedGoogle Scholar
• Shimazaki C, Inaba T, Okano A, Hatsuse M, Takahashi R, Hirai H, et al. Clinical characteristics of B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS): comparison of CD5+ with CD5-B-LAHS. Intern Med 2001; 40: 878–882
   PubMed Web of Science ®Google Scholar
• Stein H, Mason D Y, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848
   PubMed Web of Science ®Google Scholar
• Tilly H, Gaulard P, Lepage E, Dumontet C, Diebold J, Plantier I, et al. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood 1997; 90: 3727
   PubMed Web of Science ®Google Scholar
• Gascoyne R D, Aoun P, Wu D, Chhanabhai M, Skinnider B F, Greiner T C, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999; 93: 3913–3921
   PubMed Web of Science ®Google Scholar
• Belhadj K, Reyes F, Farcet J P, Tilly H, Bastard C, Angonin R, et al. Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 2003; 102: 4261–4269
   PubMed Web of Science ®Google Scholar
• Zidan J, Hussein O, Basher W, Zohar S. Serum CA125: a tumor marker for monitoring response to treatment and follow-up in patients with non-Hodgkin's lymphoma. Oncologist 2004; 9: 417–421
   PubMed Web of Science ®Google Scholar
• Zacharos I D, Efstathiou S P, Petreli E, Georgiou G, Tsioulos D I, Mastorantonakis S E, et al. The prognostic significance of CA 125 in patients with non-Hodgkin's lymphoma. J Haematol 2002; 69: 221–226
   PubMed Web of Science ®Google Scholar
• Tsuda H. Hemophagocytic syndrome (HPS) in children and adults. Int J Hematol 1997; 65: 215–226
   PubMed Web of Science ®Google Scholar
• Sanada S, Ookawara S, Shindo T, Morino K, Ishikawa H, Suzuki M. A case report of the effect of plasma exchange on reactive hemophagocytic syndrome associated with toxic shock syndrome. Ther Apher Dial 2004; 8: 503–506
   PubMed Web of Science ®Google Scholar
• Coman T, Dalloz M A, Coolen N, Heshmati F, Pene F, Cariou A, et al. Plasmapheresis for the treatment of acute pancreatitis induced by hemophagocytic syndrome related to hypertriglyceridemia. J Clin Apher 2003; 18: 129–131
   PubMed Web of Science ®Google Scholar
• Yanagiya N, Takahashi N, Nakae H, Kume M, Chubachi A, Miura I. Plasma exchange and continuous hemodiafiltration as an initial treatment for diffuse large B-cell lymphoma-associated hemophagocytic syndrome. Rinsho Ketsueki 2002; 43: 35–40
   PubMedGoogle Scholar